老年高血压刘力生(英文）PPT.pptVIP

Hypertension in the Very ElderlyLisheng LIU;Epidemiology HYVET Study ;The prevalence of hypertension in elderly population for China Japan from the national surveys conducted in 1992 1993;The effect of SBP on stroke mortality by age groups in Chinese elderly populations;Blood pressure and stroke mortality in the Chinese elderly cohort (n=4814) ;Blood pressure and stroke mortality in the Chinese elderly cohort (n=4814) ;The effects of BP on the risk of stroke mortality by age gr. in the elderly (Cox proportional hazard regression model, controlled for age and smoking, stratified by sex);Stroke mortality (per 100,000 population per year) of elderly (≧ 80yrs) in Asia in the latest available year;; BMI Hypertension Prevalence （3257 sub., Beijing);Metabolic Syndrome in Beijing （1827 sub., 2000） ;Overweight Obesity in Beijing （1827 sub., 2000） ;BMI 5 Yr. All Cause Mortality;Cognitive Function 5 Yr. Survival Rate;Renal Function (CISC cohort) ;GFR in each age group (weighted and not);The over-80’s are the fastest-growing group on the planet Age and SBP are two major components of CV risk Antihypertensive therapy reduces CV risk and mortality in patients under 80;Epidemiology HYVET Study ;;Baseline Data (Previous Cardiovascular History);;Reported characteristics of subjects at entry to the HYVET 1) in China and 2) in the other Countries. Statistical comparisons include a gender x region interaction term;?Gender difference(P0.05); ?Gender difference（P0.0 I）;＊＊Regional difference (P0.01)＊Regional difference (P0.05);￥Gender regional interaction term (P0.05) ￥￥ Gender regional interaction term (P0.01);Chinese subjects in HYVET;Blood pressure separation;All stroke (30% reduction);Total Mortality (21% reduction);Fatal Stroke (39% reduction);Heart Failure (64% reduction);0;Per-Protocol;Biochemical Changes from Baseline (2 year cohort);Safety;Conclusions;Cautions;Characteristics of Very Elderly Hypertensive Patients with Atrial Fibrillation (AF) in HYVET;Atria